verndariinc.comAbout company
Verndari was founded with the goal to eliminate needle phobia and the need for the cold chain with a cost-effective simple-to-use vaccination kit that can be mass produced.Verndari is focused on the influenza vaccine. THey have developed a new method for making the influenza vaccine antigen in mammalian cells. This presentation of the influenza vaccine allows the use of the FDA approved surrogate markers of potency and efficacy. These surrogate markers enable rapid development of manufacturing capacity and rapid clinical trial demonstration of efficacy. This new method of influenza vaccine antigen production coupled with the high-volume automated production of a room temperature stable single-dose vaccination kit may enable a rapid response platform capable of addressing pandemic biological threats.
